glyburide and glucagon-like peptide 1

glyburide has been researched along with glucagon-like peptide 1 in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (15.63)	18.2507
2000's	12 (37.50)	29.6817
2010's	13 (40.63)	24.3611
2020's	2 (6.25)	2.80

Authors

Authors	Studies
Habener, JF; Holz, GG; Kühtreiber, WM	1
Atillasoy, EJ; Burtis, WJ; Gaich, G; Ganz, MB; Orloff, JJ; Stewart, AF	1
Andrews, KM; Hargrove, DM; Nardone, NA; Parker, JC; Persson, LM; Shepherd, KL; Stevenson, RW	1
Efendic, S; Guenifi, A; Gutniak, MK; Hellström, PM; Holst, JJ; Juntti-Berggren, L	1
Bataille, D; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D	1
De Proft, R; Dejonghe, S; Gorus, F; Ling, Z; Pipeleers, D; Schuit, F; Winnock, F	1
Briaud, I; Dickson, LM; Lingohr, MK; Rhodes, CJ; Wrede, CE	1
Gribble, FM; Reimann, F; Simpson, AK; Williams, L	1
Croom, DK; Lenhard, JM; Minnick, DT	1
Edwardson, JM; Hays, LB; McCuaig, JF; Philipson, LH; Rhodes, CJ; Wang, Y; Wicksteed, B	1
Clark, R; Inoue, T; Nagakura, T; Saeki, T; Shinoda, M; Sugaya, Y; Tanaka, I; Yamamoto, E; Yamazaki, K; Yasuda, N	1
Chen, J; Hermansen, K; Jeppesen, PB; Nordentoft, I	1
El-Ouaghlidi, A; Foley, J; Holmes, D; Holst, JJ; Nauck, MA; Rehring, E; Schweizer, A	1
Basu, A; Basu, R; Charkoudian, N; Joyner, MJ; Rizza, RA; Schrage, W	1
Hayakawa, M; Matsuyama-Yokono, A; Nakano, R; Shibasaki, M; Shiraki, K; Someya, Y; Tahara, A	1
Chevalier, S; Gougeon, R; Lamarche, M; Morais, JA; Mourad, C	1
Dhillon, S; Weber, J	1
Kaku, K; Nishida, T; Rasmussen, MF; Seino, Y	1
Chen, B; Ernsberger, P; Escobedo, LV; Hou, D; Koletsky, MS; Koletsky, RJ; Moore, A	1
Bain, SC; Bodvarsdottir, TB; Bracken, RM; Deacon, CF; Dunseath, G; Holst, JJ; Lowe, GD; Luzio, S; Prior, SL; Rumley, A; Stephens, JW; Wareham, K	1
Baik, HW; Choi, KJ; Kim, BJ; Kim, JY; Lee, SK; Lim, DM; Moon, CI; Park, HS; Park, KY	1
Cockerham, RE; Dotson, CD; Geraedts, MC; Hajnal, A; Markwardt, ML; Munger, SD; Nkobena, A; Rizzo, MA; Takahashi, T; Vigues, S	1
Chen, M; Guo, Z; Hao, J; Houze, J; Lin, DC; Lopez, E; Luo, J; Ma, Z; Nguyen, K; Rulifson, IC; Tian, B; Tian, L; Tran, T; Wang, Y; Zhang, Y	1
Ananthakrishnan, K; Anderson, M; Chung, WJ; Hart, NJ; Limesand, SW; Lynch, RM; Patek, R; Vagner, J; Weber, C; Zhang, Z	1
Aragonés, A; del Val, F; López, J; Luque, A; Sastre, J	1
Bayram, Z; Nacitarhan, C; Ozdem, SS	1
Jyotaki, M; Ninomiya, Y; Sanematsu, K; Shigemura, N; Yoshida, R	1
Axell, RG; Brown, AJ; Clarke, SJ; Dutka, DP; Giblett, JP; Hoole, SP; McCormick, L; O'Sullivan, M; Read, PA; Reinhold, J; West, NE; White, PA	1
Emfinger, CH; Hruz, PW; Hung, P; McAllister, W; Nichols, CG; Remedi, MS; Welscher, A; Yan, Z	1
Hart, NJ; Limesand, SW; Lynch, RM; Papas, KK; Vagner, J; Weber, C	1
Bai, XJ; Hao, JT; Wang, J; Yan, CP; Yang, CH; Zhang, WF; Zhao, ZQ; Zheng, RH	1
Kimber-Trojnar, Ż; Niebrzydowska, M; Pilszyk, A; Pilszyk, Z; Wierzchowska-Opoka, M	1

Reviews

1 review(s) available for glyburide and glucagon-like peptide 1

Article	Year
Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus. International journal of molecular sciences, 2022, Sep-03, Volume: 23, Issue:17 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Incretins; Metformin; Pregnancy	2022

Trials

6 trial(s) available for glyburide and glucagon-like peptide 1

Article	Year
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes care, 1996, Volume: 19, Issue:8 Topics: Analysis of Variance; Animals; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glyburide; Humans; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Peptide Fragments; Perfusion; Protein Precursors; Rats; Rats, Sprague-Dawley; Treatment Failure	1996
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:11 Topics: Adamantane; Adult; Algorithms; C-Peptide; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glyburide; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Nitriles; Pyrrolidines; Vildagliptin	2007
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:5 Topics: Acetylcholine; Adult; Blood Glucose; C-Reactive Protein; Drug Interactions; Endothelium, Vascular; Female; Forearm; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Nitroprusside; Plethysmography; Regional Blood Flow; Sulfonylurea Compounds; Vasodilator Agents	2007
Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes. Current medical research and opinion, 2010, Volume: 26, Issue:5 Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Glucagon-Like Peptide 1; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Liraglutide; Placebos	2010
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes research and clinical practice, 2011, Volume: 94, Issue:2 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; F2-Isoprostanes; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Metformin; Middle Aged; Oxidative Stress; Piperidines; Postprandial Period; Time Factors; Treatment Outcome; Wales	2011
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies. Cardiovascular diabetology, 2016, Jul-19, Volume: 15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Vessels; Echocardiography, Stress; Female; Glucagon-Like Peptide 1; Glyburide; Humans; Male; Middle Aged; Myocardial Ischemia; Potassium Channels; Ventricular Dysfunction, Left; Young Adult	2016

Other Studies

25 other study(ies) available for glyburide and glucagon-like peptide 1

Article	Year
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature, 1993, Jan-28, Volume: 361, Issue:6410 Topics: Animals; Cells, Cultured; Cyclic AMP; Drug Synergism; Electric Conductivity; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Islets of Langerhans; Male; Membrane Potentials; Peptide Fragments; Peptides; Rats; Thionucleotides	1993
Amino-terminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology, 1993, Volume: 132, Issue:3 Topics: Animals; Binding Sites; Calcium; Cell Membrane; Cyclic AMP; Cytosol; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glyburide; Insulinoma; Kinetics; Pancreatic Neoplasms; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Peptides; Proteins; Rats; Rats, Inbred WF; Tumor Cells, Cultured	1993
Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo. Metabolism: clinical and experimental, 1996, Volume: 45, Issue:3 Topics: Animals; Fasting; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley	1996
Miniglucagon: a local regulator of islet physiology. Annals of the New York Academy of Sciences, 1998, Dec-11, Volume: 865 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Peptides	1998
Correlation between GABA release from rat islet beta-cells and their metabolic state. American journal of physiology. Endocrinology and metabolism, 2002, Volume: 282, Issue:4 Topics: 1-Methyl-3-isobutylxanthine; 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Calcium; Culture Media, Conditioned; Cycloheximide; Diazoxide; gamma-Aminobutyric Acid; Glucagon; Glucagon-Like Peptide 1; Glucose; Glutamate Decarboxylase; Glyburide; Islets of Langerhans; Male; Mannoheptulose; Oxidation-Reduction; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Verapamil	2002
Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes, 2003, Volume: 52, Issue:4 Topics: Animals; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Humans; Islets of Langerhans; Isoquinolines; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Sulfonamides; Verapamil	2003
A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes, 2003, Volume: 52, Issue:5 Topics: Animals; Carbohydrates; Cell Line; Fructose; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glyburide; Hypoglycemic Agents; Islets of Langerhans; Kinetics; Mannitol; Mice; Monosaccharide Transport Proteins; Peptide Fragments; Phlorhizin; Protein Precursors	2003
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Biochemical and biophysical research communications, 2004, Nov-05, Volume: 324, Issue:1 Topics: Aging; Animals; Blood Glucose; Cell Membrane; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Hemoglobins; Hypoglycemic Agents; Insulin; Kidney; Liver; Male; Metformin; Peptide Fragments; Pioglitazone; PPAR gamma; Protein Precursors; Rats; Rats, Zucker; Thiazolidinediones	2004
Intragranular targeting of syncollin, but not a syncollinGFP chimera, inhibits regulated insulin exocytosis in pancreatic beta-cells. The Journal of endocrinology, 2005, Volume: 185, Issue:1 Topics: Animals; Carrier Proteins; Cell Line; Exocytosis; Glucagon; Glucagon-Like Peptide 1; Glucose; Glyburide; Green Fluorescent Proteins; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Proteins; Microscopy, Confocal; Microscopy, Fluorescence; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Stimulation, Chemical	2005
Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 320, Issue:2 Topics: Animals; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glyburide; Imidazoles; Insulin; Male; Mice; Mice, Inbred C57BL; Nateglinide; Phenylalanine; Protease Inhibitors; Pyridazines; Rats; Rats, Wistar; Tosyl Compounds	2007
Stevioside counteracts the glyburide-induced desensitization of the pancreatic beta-cell function in mice: studies in vitro. Metabolism: clinical and experimental, 2006, Volume: 55, Issue:12 Topics: Animals; Dimethyl Sulfoxide; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Female; Glucagon-Like Peptide 1; Glucose Transporter Type 2; Glucosides; Glyburide; Homeodomain Proteins; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Trans-Activators	2006
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice. Metabolism: clinical and experimental, 2009, Volume: 58, Issue:3 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gliclazide; Glucagon-Like Peptide 1; Glucose Intolerance; Glyburide; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred ICR; Niacinamide; Piperidines; Pyrrolidines; Sulfonylurea Compounds	2009
Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:8 Topics: Aged; Amino Acids; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptides; Fasting; Gastric Emptying; Glucagon-Like Peptide 1; Glyburide; Humans; Hunger; Hypoglycemic Agents; Insulin; Leptin; Male; Metformin; Middle Aged; Postprandial Period; Satiation; Thiazolidinediones	2009
Saxagliptin. Drugs, 2009, Oct-22, Volume: 69, Issue:15 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glyburide; Humans; Metformin; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats. Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:3 Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles	2011
Exendin-4 protects against sulfonylurea-induced β-cell apoptosis. Journal of pharmacological sciences, 2012, Volume: 118, Issue:1 Topics: Animals; Apoptosis; Calcium; Cell Line; Cricetinae; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Exenatide; Glucagon-Like Peptide 1; Glyburide; Hypoglycemic Agents; Insulin-Secreting Cells; Peptides; Rats; Rats, Sprague-Dawley; Venoms	2012
Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery. American journal of physiology. Endocrinology and metabolism, 2012, Aug-15, Volume: 303, Issue:4 Topics: Animals; Cells, Cultured; Feces; Fructose; Gastric Bypass; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Glyburide; Homeostasis; Hypoglycemic Agents; Ileum; Insulin; Insulin Secretion; Intestine, Large; Islets of Langerhans; KATP Channels; Mice; Rats; Receptors, G-Protein-Coupled; Sucrose; Taste Buds	2012
Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Metabolism: clinical and experimental, 2013, Volume: 62, Issue:1 Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Nateglinide; Peptides; Phenylalanine; Pyrazines; Sitagliptin Phosphate; Specific Pathogen-Free Organisms; Triazoles; Venoms	2013
Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells. Chembiochem : a European journal of chemical biology, 2014, Jan-03, Volume: 15, Issue:1 Topics: Amino Acid Sequence; Animals; Cells, Cultured; Fluorescent Dyes; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glyburide; Hypoglycemic Agents; Insulin-Secreting Cells; Molecular Sequence Data; Protein Binding; Rats; Receptors, Glucagon; Structure-Activity Relationship; Sulfonylurea Receptors	2014
Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes. Diabetes care, 2014, Volume: 37, Issue:3 Topics: Adolescent; Adult; Diabetes Mellitus; DNA; DNA Mutational Analysis; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Mutation; Potassium Channels, Inwardly Rectifying; Pyrazines; Sitagliptin Phosphate; Time Factors; Triazoles	2014
Effects of glucagon-like peptide-1 in diabetic rat small resistance arteries. Journal of cardiovascular pharmacology, 2014, Volume: 64, Issue:3 Topics: 4-Aminopyridine; Animals; Apamin; Arteries; Charybdotoxin; Cyclic GMP; Diabetes Mellitus, Experimental; Endothelium, Vascular; Glucagon-Like Peptide 1; Glyburide; Male; Nitric Oxide; Peptide Fragments; Peptides; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase	2014
Leptin suppresses sweet taste responses of enteroendocrine STC-1 cells. Neuroscience, 2016, 09-22, Volume: 332 Topics: Animals; Calcium; Cell Line; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glyburide; Immunohistochemistry; KATP Channels; Leptin; Mice; Polymerase Chain Reaction; Potassium Channel Blockers; Receptors, G-Protein-Coupled; Receptors, Leptin; Taste; Voltage-Sensitive Dye Imaging	2016
Contribution of systemic inflammation to permanence of K American journal of physiology. Endocrinology and metabolism, 2018, 12-01, Volume: 315, Issue:6 Topics: Animals; Blood Glucose; Cytokines; Diabetes Mellitus; Glucagon; Glucagon-Like Peptide 1; Glyburide; Inflammation; Insulin; Insulin Resistance; Leptin; Mice; Mice, Transgenic; Mutation; Potassium Channels, Inwardly Rectifying	2018
Multivalent activation of GLP-1 and sulfonylurea receptors modulates β-cell second-messenger signaling and insulin secretion. American journal of physiology. Cell physiology, 2019, 01-01, Volume: 316, Issue:1 Topics: B-Lymphocytes; Female; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Middle Aged; Receptors, Glucagon; Second Messenger Systems; Sulfonylurea Receptors	2019
Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels. Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:1 Topics: Animals; Apoptosis; Cardiomegaly; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glyburide; KATP Channels; Liraglutide; Male; Random Allocation; Rats; Rats, Sprague-Dawley	2021